Digital health promises to be the pinnacle of healthcare's revolution. But we're still tangled in stakeholder uncertainty, hazy go-to-market models, insufficient data capabilities, and a fragmented value chain that prevents digital health scale.
Without clear steps to success in the near future, digital health may slip into pharma's pile of abandoned pilots.
To seize digital health's opportunities, pharma must redesign commercial models, co-create access frameworks, and unite stakeholders behind a digital.
Reuters Events: Pharma Digital Health Europe 2023 (9-10 November, London) will bring together over 200 digital health change-makers from across the ecosystem to redesign commercial models, co-create access frameworks, and learn from successful in-market solutions.
We've collaborated with industry leaders to bring you an agenda rich in case studies and connected perspectives. Our speaker line up includes:
- Gregoire Guillet, Chief Business and Value Officer, WeHealth Digital Factory, Servier
- Linda Scarazzini, SVP Pharmacovigilance, Chief Safety Officer, AbbVie
- Philippe Pinton, SVP, Clinical and Translational Sciences, Global Head, Ferring
- Catarina Santos, Executive Director Launch Medical Region Europe, Novartis
- Sonny Shergill, VP Commercial Digital Health, AstraZeneca
- Ipek Ozer Stillman, Head, Global Health Economics, Payer Value & Patient Access, Takeda
- Tiana Homsani, Global Head of Marketing Excellence, Abbott
Download the info pack to explore the agenda, speakers and ways to attend.
No comments